The Baculoviral IAP Repeat Containing 3 (BIRC3) is associated with marginal zone B-cell lymphoma and was suggested as a novel NK cell immune checkpoint in cancer [54, 55]. The gene discussed is BIRC3; the disease is marginal zone lymphoma.